Medication

FILE - In this Thursday, March 14, 2008 file photo, a woman rides a bicycle past Changzhou SPL in Changzhou, China. The FDA did not open its first permanent offices in China and India until 2008 and 2009, respectively. That followed dozens of deaths and hundreds of allergic reactions in the U.S. linked to the contaminated blood thinner heparin made at this Chinese facility. (AP Photo/Eugene Hoshiko)
August 28, 2019 - 10:44 pm
WASHINGTON (AP) — U.S. health officials on Wednesday tried to reassure patients that they face very low risks from ongoing contamination problems with widely prescribed blood pressure drugs. Drugmakers have issued more than 50 recalls since last July linked to low levels of a probable cancer-...
Read More
FILE - This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. State attorneys general and lawyers representing local governments said Tuesday, Aug. 27, 2019, they are in active negotiations with Purdue Pharma, maker of the prescription painkiller OxyContin, as they attempt to reach a landmark settlement over the nation's opioid crisis. (AP Photo/Toby Talbot, File)
August 28, 2019 - 10:53 am
COLUMBUS, Ohio (AP) — Purdue Pharma and the thousands of state and local governments suing the maker of OxyContin over the nation's deadly opioid crisis are negotiating a $10 billion to $12 billion settlement under which the Sackler family would give up ownership of the company, according to...
Read More
FILE - This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. State attorneys general and lawyers representing local governments said Tuesday, Aug. 27, 2019, they are in active negotiations with Purdue Pharma, maker of the prescription painkiller OxyContin, as they attempt to reach a landmark settlement over the nation's opioid crisis. (AP Photo/Toby Talbot, File)
August 28, 2019 - 9:10 am
COLUMBUS, Ohio (AP) — States and local governments are in talks to settle lawsuits with the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation's opioid crisis. Suits filed by more than 2,000 state, local and tribal...
Read More
FILE - This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. State attorneys general and lawyers representing local governments said Tuesday, Aug. 27, 2019, they are in active negotiations with Purdue Pharma, maker of the prescription painkiller OxyContin, as they attempt to reach a landmark settlement over the nation's opioid crisis. (AP Photo/Toby Talbot, File)
August 28, 2019 - 4:24 am
COLUMBUS, Ohio (AP) — State attorneys general and lawyers representing local governments said Tuesday they are in active settlement talks with Purdue Pharma, the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation's...
Read More
FILE - This booking photo provided by the Weber County Sheriff's Office shows Aaron Michael Shamo. Shamo, a 29-year-old man at the center of a multimillion-dollar dark web opioid drug ring case says he saw himself as helping people get prescription drugs they needed while making money for himself and his friends. Shamo took the stand in a federal courtroom in Salt Lake City on Tuesday, Aug. 27, 2019, miles from the suburban basement where he and a friend pressed thousands of fentanyl-laced fake oxycodone pills that were shipped to people all over the country. (Weber County Sheriff's Office via AP, File)
August 27, 2019 - 7:29 pm
SALT LAKE CITY (AP) — Prosecutors have called Aaron Shamo the kingpin of a multimillion-dollar drug ring that shipped hundreds of thousands of potentially deadly opioid pills across the country from a suburban Utah basement. Shamo took the witness stand Tuesday at his trial and downplayed his role...
Read More
Judge Thad Balkman enters the courtroom before he delivers his decision in the opioid trial at the Cleveland County Courthouse in Norman, Okla., Monday, Aug. 26, 2019. Balkman ruled in favor of the state of Oklahoma and ordered Johnson and Johnson to pay $572 million to a plan to abate the opioid crisis. (Chris Landsberger/The Oklahoman via AP, Pool)
August 27, 2019 - 2:06 pm
Johnson & Johnson investors exhaled in relief Tuesday, pushing up shares higher after an Oklahoma judge imposed a $572 million verdict for the health care giant's role in the nation's opioid crisis. During the seven week trial state prosecutors who sought up to $17 billion described J&J as...
Read More
August 26, 2019 - 1:31 pm
ATLANTA (AP) — Prescriptions for opioids, as well as possible indicators of abuse, continue to fall in Georgia. The Atlanta Journal-Constitution reports new figures released by the state Public Health Department show prescriptions for opioids fell 13% from 2016 to 2018. Preliminary numbers show...
Read More
August 21, 2019 - 3:53 pm
SANFORD, N.C. (AP) — Drug giant Pfizer is expanding its North Carolina manufacturing plant for gene-therapy medicines to treat rare diseases, adding about 300 jobs. The New York City-based company said Wednesday it plans to spend about $500 million to expand its plant in Sanford to improve...
Read More
August 20, 2019 - 5:17 pm
Two pharmaceutical companies have reached settlements totaling $15 million to avoid being defendants in the first federal trial on the drug industry's accountability for a nationwide opioid crisis. Dublin, Ireland-based Endo Pharmaceuticals announced Tuesday that it has agreed to pay the Ohio...
Read More
FILE- In this July 10, 2018, file photo bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J. Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. (AP Photo/Julio Cortez, File)
August 19, 2019 - 4:41 pm
TRENTON, N.J. (AP) — Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. After years of frequent list price hikes, many drugmakers are showing some restraint, according to the...
Read More

Pages